Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease?
β Scribed by Ashwin N. Ananthakrishnan; Dawn B. Beaulieu; Alex Ulitsky; Yelena Zadvornova; Sue Skaros; Kathryn Johnson; Amar Naik; Lilani Perera; Mazen Issa; David G. Binion; Kia Saeian
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 114 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A longitudinal, cohort study was performed to characterize the clinical features of patients with small-duct primary sclerosing cholangitis (PSC) occurring with and without inflammatory bowel disease (IBD) and to determine the influence of IBD and the effect of ursodeoxycholic acid (UDCA) therapy on
## Background: Crohn's disease and ulcerative colitis, referred to as inflammatory bowel diseases, affect mainly young adults and have an elevated morbidity and a negative effect on quality of life. this study aimed to compare the health-related quality of life between 2 randomized groups of patien
Inflammatory bowel disease (IBD), which encompasses Crohn's disease (CD) and ulcerative colitis (UC), are chronic and debilitating conditions with unpredictable courses and complicated treatment. Pediatric IBD carries implications that extend beyond the health of the gastrointestinal tract. When the
## Background: Inflammatory bowel diseases (ibd) such as ulcerative colitis (uc) and crohn's disease (cd) have great impact on patients' health-related quality of life (hrqol). the aim of this study was to develop an integrated medical and psychological/ psychosocial group-based intervention progra
## Background: Approximately 20%-25% of all inflammatory bowel disease (ibd) cases have an onset in childhood or adolescence. beyond disease severity, little is known regarding determinants of health-related quality of life (hrqol) in this population. this study aimed to identify behavioral correla